Heska to Present at Upcoming J.P. Morgan Annual Healthcare Conference
01/05/2021 - 08:30 AM
LOVELAND, Colo. , Jan. 5, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson , Heska's President & Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday January 13, 2021 at 2 p.m. Eastern Time .
Mr. Wilson's presentation will be available to registered conference attendees in a live video format via the conference website. A live audio-only version of the presentation and question and answer session will be available to non-registered attendees at Heska Audio-Only J.P. Morgan Conference Presentation . The webcast and presentation will be archived on Heska's website shortly after the event and a replay will be available for 90 days following the conference.
Mr. Wilson and members of Heska management will also be participating in one-on-one meetings on January 13 th . To request a meeting, please contact J.P. Morgan at 1x1@jpmorgan.com or Heska Investor Relations at investorrelations@heska.com .
For more information regarding the J.P. Morgan 2020 Healthcare Conference, visit: J.P. Morgan Healthcare Conference Website .
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
http://www.prnewswire.com/news-releases/heska-to-present-at-upcoming-jp-morgan-annual-healthcare-conference-301200833.html
SOURCE Heska Corporation
HSKA Rankings
N/A Ranked by Stock Gains
HSKA Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Loveland
About HSKA
heska corporation (nasdaq: hska) is dedicated to perfecting and supporting the core technology and services that truly impact the quality of pet care and help to ensure positive outcomes for veterinarians and their patients. heska was created by veterinary professionals for veterinary professionals. our pledge to customers is to stand behind sound science, following best medical practices. heska’s line of diagnostic and imaging advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. heska also leads the way with the latest hd digital radiography, digital ultrasound, and pacs imaging technologies from cuattro. we help veterinary practices discover the right product solutions for their clients and patients; improving patient care, productivity and profitability. heska’s corporate headquarters are in loveland, colorado. we provide our products a
